Skip to content

Integra LifeSciences Announces Participation in Upcoming Investor Conferences

<< Back

Press Release

Aug 23, 2022

Integra LifeSciences Announces Participation in Upcoming Investor Conferences

PRINCETON, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences:

  • On September 7, 2022, Jan De Witte, chief executive officer will present at the Wells Fargo 2022 Healthcare Conference in Boston, MA at 8:35am ET.
  • On September 12, 2022, Carrie Anderson, executive vice president and chief financial officer will present at the Morgan Stanley Annual Global Healthcare Conference in New York, NY at 11:05am ET.

Webcast information can be found on the Company’s website at Investor Relations.

About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Aurora®, Bactiseal®, BioD, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, Licox® , MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen® , NeuraWrap , PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit

Investor Relations:
Chris Ward
(609) 772-7736

Media Contact:
Laurene Isip
(609) 208-8121